| Name | Title | Contact Details |
|---|
T1D Exchange, a nonprofit organization, is a dynamic, multi-purpose, real-world patient data platform designed to accelerate all aspects of drug and device development. T1D Exchange has established a unique model to speed better treatments, therapies and research for type 1 diabetes (T1D). The Exchange consists of an integrated Clinic Network of 65+ clinics across the U.S., a Clinic Registry of 26,000 well-characterized patients, a Biorepository, and Glu, an online community with mobile capabilities for people touched by type 1 diabetes. The T1D Exchange fosters faster and more fluid information transfer and sharing among diabetes patients, physicians, researchers, and pharma, medical device, education, and outreach organizations.
At Clinipace, a global, full-service contract research organization (CRO), our approach to clinical research is personal. We deliver a level of collaboration and flexibility not possible in a traditional CRO environment. Our personalized services and solutions, local regulatory expertise and therapeutic leadership are designed to face the most difficult industry challenges across all major therapeutic areas including oncology, gastroenterology, nephrology and urology. We strive to improve the way clinical research is performed and impact the future of health care using the most advanced technology and a CHALLENGE ACCEPTED approach. In April 2021, Clinipace & dMed merged creating a differentiated mid-size CRO with the largest Asia-Pacific presence. We are proud to have such a strong group of global investors focused on improving healthcare outcomes and giving sponsors a better CRO choice. dMed`s 2019 acquisition of Target Health commenced the process of building a Next Generation global CRO for biotech and pharmaceutical companies. Our investors have invested over $230M to build the next great global CRO. dMed`s acquisition of Target Health in 2019 began dMed`s evolution from a local to global CRO. Target Health LLC is owned by dMedClinical Co. Ltd., a privately held company that is majority owned, operated, managed, and controlled by a U.S. citizen and foreign entities located in the People`s Republic of China. Dr. Lingshi Tan, is the aforementioned U.S. citizen currently residing in Shanghai, China. Dr. Tan moved to Shanghai (from New York) to become Pfizer`s VP of Worldwide Development Operations, and Chairman and General Manager of Pfizer (China) Research & Development Co. Dr. Tan founded dMed in 2016 to satisfy the local demand for a high quality, responsive, flexible CRO.
Blood Systems is a Scottsdale, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Mental Health Centers of Western Illinois is a Pittsfield, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
MCPN provides excellent health-related services focusing on the underserved. MCPN has one of the largest population bases of any community health center in Colorado. MCPN is dedicated to being a positive work place with employees that are committed to being focused and disciplined team members. MCPN is also dedicated to taking care of our patients and our employees to ensure the best quality of life. Career Opportunities ! MCPN is committed to quality growth and is interested in speaking with unique individuals who want more in a career. Currently we are looking for Family Practice Physicians, Physician Assistants, Nurse Practitioners, Dentists, Dental Hygienists, and other Business Professionals. We offer top compensation, world class benefits, flexible hours and a belief in work/life balance. We look forward to hearing from you! Make your career exceptional by joining us.